國立虎尾科技大學 |

Neurodegenerative Diseases Biomarkers = Towards Translating Research to Clinical Practice /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Neurodegenerative Diseases Biomarkers/ edited by Philip V. Peplow, Bridget Martinez, Thomas A. Gennarelli.
其他題名:	Towards Translating Research to Clinical Practice /
其他作者:	Gennarelli, Thomas A.
面頁冊數:	XVIII, 565 p. 48 illus., 42 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Neuroscience. -
電子資源:	https://doi.org/10.1007/978-1-0716-1712-0
ISBN:	9781071617120

Neurodegenerative Diseases Biomarkers = Towards Translating Research to Clinical Practice /
Neurodegenerative Diseases BiomarkersTowards Translating Research to Clinical Practice /[electronic resource] :edited by Philip V. Peplow, Bridget Martinez, Thomas A. Gennarelli. - 1st ed. 2022. - XVIII, 565 p. 48 illus., 42 illus. in color.online resource. - Neuromethods,1731940-6045 ;. - Neuromethods,192.

Prevalence, Needs, Strategies, and Risk Factors for Neurodegenerative Diseases. Activation of Microglia and Macrophages in Neurodegenerative Diseases -- Activation of Astrocytes in Neurodegenerative Diseases -- Tau Pathology in Neurodegenerative Diseases -- Role of SIRT3 and Mitochondrial Dysfunction in Neurodegeneration -- Oxidative Stress and Cellular Dysfunction in Neurodegeneratiove Disease -- Biomarkers in Parkinson’s Disease -- Metabolomic Biomarkers in Parkinson’s Disease -- Neuroinflammation in Huntington’s Disease -- Biomarkers in Huntington Disease -- Biofluid Biomarkers of Amyotrophic Lateral Sclerosis -- MicroRNAs in Blood Serum, Blood Plasma, and Cerebrospinal Fluid as Diagnostic Biomarkers of Alzheimer’s Disease -- Tau Biomarkers for Long-Term Effects of Neurotrauma: Technology Versus the Null Hypothesis -- Impedimetric Immunosensing for Neuroinflammatory Biomarker Profiling -- Aptamers Detection of Neurodegenerative Disease Biomarkers -- Possible Biomarkers for Frontotemporal Dementia and to Differentiate from Alzheimer’s Disease and Amyotrophic Lateral Sclerosis -- TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders -- Validation of Diffusion Kurtosis Imaging as an Early Stage Biomarker of Parkinson’s Disease in Animal Models -- Imaging Biomarkers in Huntington’s Disease -- Imaging Biomarkers in Amyotrophic Lateral Sclerosis -- Trends in Biomarkers of Neurodegenerative Diseases.

This volume presents recent data on the latest achievements in new and emerging technologies for biomarkers and for innovations in their assessment. The chapters cover topics such as activation of microglia and macrophages in neurodegenerative diseases; oxidative stress and cellular dysfunction in neurodegenerative diseases; TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders; and imaging biomarkers in Huntington's disease and amyotrophic lateral sclerosis. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and comprehensive, Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice is a valuable resource for both experimental and clinical experts in the field of neurodegenerative diseases who are looking to expand their knowledge of novel biomarkers in different types of neurodegenerative diseases.

ISBN: 9781071617120

Standard No.: 10.1007/978-1-0716-1712-0doiSubjects--Topical Terms:

569964
Neuroscience.

LC Class. No.: RC321-580

Dewey Class. No.: 612.8

Neurodegenerative Diseases Biomarkers = Towards Translating Research to Clinical Practice /
LDR:03828nam a22003855i 4500 001 1090037
003 DE-He213
005 20220120203207.0
007 cr nn 008mamaa
008 221228s2022 xxu| s |||| 0|eng d
020 $a 9781071617120 $9 978-1-0716-1712-0
024 7 $a 10.1007/978-1-0716-1712-0 $2 doi
035 $a 978-1-0716-1712-0
050 4 $a RC321-580
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 612.8 $2 23
245 1 0 $a Neurodegenerative Diseases Biomarkers $h [electronic resource] : $b Towards Translating Research to Clinical Practice / $c edited by Philip V. Peplow, Bridget Martinez, Thomas A. Gennarelli.
250 $a 1st ed. 2022.
264 1 $a New York, NY : $b Springer US : $b Imprint: Humana, $c 2022.
300 $a XVIII, 565 p. 48 illus., 42 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Neuromethods, $x 1940-6045 ; $v 173
505 0 $a Prevalence, Needs, Strategies, and Risk Factors for Neurodegenerative Diseases. Activation of Microglia and Macrophages in Neurodegenerative Diseases -- Activation of Astrocytes in Neurodegenerative Diseases -- Tau Pathology in Neurodegenerative Diseases -- Role of SIRT3 and Mitochondrial Dysfunction in Neurodegeneration -- Oxidative Stress and Cellular Dysfunction in Neurodegeneratiove Disease -- Biomarkers in Parkinson’s Disease -- Metabolomic Biomarkers in Parkinson’s Disease -- Neuroinflammation in Huntington’s Disease -- Biomarkers in Huntington Disease -- Biofluid Biomarkers of Amyotrophic Lateral Sclerosis -- MicroRNAs in Blood Serum, Blood Plasma, and Cerebrospinal Fluid as Diagnostic Biomarkers of Alzheimer’s Disease -- Tau Biomarkers for Long-Term Effects of Neurotrauma: Technology Versus the Null Hypothesis -- Impedimetric Immunosensing for Neuroinflammatory Biomarker Profiling -- Aptamers Detection of Neurodegenerative Disease Biomarkers -- Possible Biomarkers for Frontotemporal Dementia and to Differentiate from Alzheimer’s Disease and Amyotrophic Lateral Sclerosis -- TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders -- Validation of Diffusion Kurtosis Imaging as an Early Stage Biomarker of Parkinson’s Disease in Animal Models -- Imaging Biomarkers in Huntington’s Disease -- Imaging Biomarkers in Amyotrophic Lateral Sclerosis -- Trends in Biomarkers of Neurodegenerative Diseases.
520 $a This volume presents recent data on the latest achievements in new and emerging technologies for biomarkers and for innovations in their assessment. The chapters cover topics such as activation of microglia and macrophages in neurodegenerative diseases; oxidative stress and cellular dysfunction in neurodegenerative diseases; TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders; and imaging biomarkers in Huntington's disease and amyotrophic lateral sclerosis. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and comprehensive, Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice is a valuable resource for both experimental and clinical experts in the field of neurodegenerative diseases who are looking to expand their knowledge of novel biomarkers in different types of neurodegenerative diseases.
650 1 4 $a Neuroscience. $3 569964
650 0 $a Neurosciences. $3 593561
700 1 $a Gennarelli, Thomas A. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1397373
700 1 $a Martinez, Bridget. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1397372
700 1 $a Peplow, Philip V. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1397371
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9781071617113
776 0 8 $i Printed edition: $z 9781071617137
776 0 8 $i Printed edition: $z 9781071617144
830 0 $a Neuromethods, $x 1940-6045 ; $v 192 $3 1388708
856 4 0 $u https://doi.org/10.1007/978-1-0716-1712-0
912 $a ZDB-2-PRO
950 $a Springer Protocols (Springer-12345)